Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Ionis Pharmaceuticals Inc’s stock clocked out at $50.43, down -0.36% from its previous closing price of $50.61. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 1.39 million shares were traded. IONS stock price reached its highest trading level at $51.25 during the session, while it also had its lowest trading level at $49.34.
Ratios:
To gain a deeper understanding of IONS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.28 and its Current Ratio is at 7.37. In the meantime, Its Debt-to-Equity ratio is 6.64 whereas as Long-Term Debt/Eq ratio is at 6.49.
On June 14, 2024, Bernstein Upgraded its rating to Mkt Perform which previously was Underperform but kept the price unchanged to $44.
Wolfe Research Upgraded its Peer Perform to Outperform on April 10, 2024, while the target price for the stock was maintained at $58.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 16 ’24 when KLEIN JOSEPH III sold 12,000 shares for $50.00 per share. The transaction valued at 600,000 led to the insider holds 0 shares of the business.
Diaz Allene M. sold 1,637 shares of IONS for $81,019 on Jul 16 ’24. The Director now owns 15,716 shares after completing the transaction at $49.49 per share. On Jun 17 ’24, another insider, BERTHELSEN SPENCER R, who serves as the Director of the company, sold 16,000 shares for $40.29 each. As a result, the insider received 644,640 and left with 147,257 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IONS now has a Market Capitalization of 7387289088 and an Enterprise Value of 7125400064. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.47 while its Price-to-Book (P/B) ratio in mrq is 24.80. Its current Enterprise Value per Revenue stands at 9.175 whereas that against EBITDA is -20.094.
Stock Price History:
The Beta on a monthly basis for IONS is 0.40, which has changed by 0.2937404 over the last 52 weeks, in comparison to a change of 0.21656322 over the same period for the S&P500. Over the past 52 weeks, IONS has reached a high of $54.44, while it has fallen to a 52-week low of $35.95. The 50-Day Moving Average of the stock is 19.03%, while the 200-Day Moving Average is calculated to be 10.41%.
Shares Statistics:
It appears that IONS traded 1.30M shares on average per day over the past three months and 1378990 shares per day over the past ten days. A total of 144.34M shares are outstanding, with a floating share count of 134.16M. Insiders hold about 8.08% of the company’s shares, while institutions hold 96.61% stake in the company. Shares short for IONS as of 1719532800 were 9520997 with a Short Ratio of 7.32, compared to 1717113600 on 8597493. Therefore, it implies a Short% of Shares Outstanding of 9520997 and a Short% of Float of 7.7199996.
